SynopsisCD62L is a 74-95 kD single chain type I glycoprotein referred to as L-selectin or LECAM-1. It is expressed on most peripheral blood B cells, subsets of T and NK cells, monocytes, granulocytes, and certain hematopoietic malignant cells. Global CD62L Antib.....
SynopsisThe global Hand Held Pulse Oximeters market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hand Held Pulse Oximeters in various end use industries. The exp.....
SynopsisThe cardiovascular system is a closed vascular system consisting of the heart and blood vessels. The global Peripheral Vascular Diagnostic Systems market size is expected to reach US$ 671 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The .....
SynopsisCell imaging is the study of examining cell structures through various devices such as microscopes to better understand cellular mechanisms to help diagnose diseases and discover drugs. There are several methods of cell imaging, which include fluorescence micr.....
Synopsis Cavitation machines are fat reduction and skin rejuvenation machines that use heat and sound waves. Cavitation machines use ultrasound and RF (radio frequency) technology to break down fat cells. They penetrate your skin, break down the fat, con.....
SynopsisPreloaded intraocular lens (IOL) insertion systems are single-use disposable devices, which offer advantage of requiring small wound size, reduced optic diameter, and are associated with less risk of postoperative endophthalmitis. Global Preloaded Inject.....
SynopsisThe global eCOA and ePRO Solutions for Clinical Trials market size was valued at USD 423.9 million in 2022 and is forecast to a readjusted size of USD 575 million by 2029 with a CAGR of 4.5% during review period. The influence of COVID-19 and the Russia-Ukrain.....
SynopsisThe global Interleukin 17A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Interleukin 17A is estimated to increase from $ mi.....
SynopsisAsparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available......
Synopsis Raloxifene, sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis .....
